Discover 120 paid clinical trials in Missoula, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 120
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Missoula MT, South Jordan UT, Albuquerque NM,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 17
Code: NCT07213973
Phase 2, Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for
Type 2 Diabetes
Location: Missoula MT, Meridian ID, Idaho Falls ID, Blackfoot ID,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07754461
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Missoula MT, Boise ID, Calgary, Kelowna, Red Deer,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Missoula MT, Kalispell MT, Great Falls MT, Boise ID,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Get alerts for new trials in your area by subscribing now
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase 3, Recruiting
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Missoula MT, Coeur d'Alene ID, Post Falls ID,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07393555
Phase 2, Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05058651
Phase 2, Phase 3, Recruiting
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07504588
Phase 2, Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 60+
Code: NCT07437950
Phase 2, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase 3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Missoula MT, Kalispell MT, Great Falls MT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06524544
Phase 3, Recruiting
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06948084
Phase 2, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,